Literature DB >> 18794254

PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study.

Andrew M Scott1, Dishan H Gunawardana, Dylan Bartholomeusz, Jayne E Ramshaw, Peter Lin.   

Abstract

UNLABELLED: The primary aim of this study was to determine the impact of PET in changing initial management plans in patients with untreated head and neck cancer. Secondary aims were to determine the incremental staging information provided by PET and to document the effect of PET on treatment outcomes.
METHODS: Patients with untreated head and neck cancer underwent PET scans. Pre-PET management plans were documented by referring clinicians unaware of the PET results, and management plan changes due to PET scan findings were documented. Follow-up to 12 mo after treatment was performed to determine actual management and clinical outcomes.
RESULTS: A total of 71 patients (median age, 56 y; 69% male) were studied. PET scans resulted in management change in 33.8% of patients. Moreover, PET was able to detect additional sites of disease in 39.4% of patients. Follow-up data showed that PET improved the classification of patients into curative and palliative categories. Trends toward inferior disease-free survival and lower complete response rates in patients with additional lesions detected on PET were demonstrated. In addition, a trend toward inferior disease-free survival in patients with a higher maximum standardized uptake value was shown.
CONCLUSION: These data unequivocally demonstrate the significant impact of PET on management and outcomes in patients with untreated head and neck cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794254     DOI: 10.2967/jnumed.108.053660

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  26 in total

Review 1.  The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.

Authors:  Giovanni Cammaroto; Natale Quartuccio; Alessandro Sindoni; Francesca Di Mauro; Federico Caobelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

2.  Impact of initial FDG PET/CT in the management plan of patients with locally advanced head and neck cancer.

Authors:  F Arias; V Chicata; M J García-Velloso; G Asín; M Uzcanga; C Eito; I Quilez; A Viudez; J Saenz; I Hernández; C Caicedo; M Errasti; M Barrado; F García-Bragado
Journal:  Clin Transl Oncol       Date:  2014-07-31       Impact factor: 3.405

Review 3.  Functional imaging in radiation therapy planning for head and neck cancer.

Authors:  Luis A Pérez Romasanta; María José García Velloso; Antonio López Medina
Journal:  Rep Pract Oncol Radiother       Date:  2013-11-09

Review 4.  Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.

Authors:  Jon Cacicedo; Arturo Navarro; Olga Del Hoyo; Alfonso Gomez-Iturriaga; Filippo Alongi; Jose A Medina; Olgun Elicin; Andrea Skanjeti; Francesco Giammarile; Pedro Bilbao; Francisco Casquero; Berardino de Bari; Alan Dal Pra
Journal:  Br J Radiol       Date:  2016-08-02       Impact factor: 3.039

5.  18F-Fluorodeoxyglucose-PET/CT in locally advanced head and neck cancer can influence the stage migration and nodal radiation treatment volumes.

Authors:  Rosario Mazzola; Pierpaolo Alongi; Francesco Ricchetti; Alba Fiorentino; Sergio Fersino; Niccolò Giaj-Levra; Matteo Salgarello; Filippo Alongi
Journal:  Radiol Med       Date:  2017-08-28       Impact factor: 3.469

6.  Early post-treatment FDG PET predicts survival after 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancer.

Authors:  Amir Sabet; Carsten Meyer; Anas Aouf; Amin Sabet; Shahab Ghamari; Claus C Pieper; Karin Mayer; Hans-Jürgen Biersack; Samer Ezziddin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-10-29       Impact factor: 9.236

7.  Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST.

Authors:  Colleen M Costelloe; Hubert H Chuang; John E Madewell; Naoto T Ueno
Journal:  J Cancer       Date:  2010-06-28       Impact factor: 4.207

8.  Intended versus inferred management after PET for cancer restaging: analysis of Medicare claims linked to a coverage with evidence development registry.

Authors:  Bruce E Hillner; Tor D Tosteson; Anna N A Tosteson; Qianfei Wang; Yunjie Song; Tracy Onega; Lucy G Hanna; Barry A Siegel
Journal:  Med Care       Date:  2013-04       Impact factor: 2.983

9.  Positron emission tomography and stage migration in head and neck cancer.

Authors:  Noam A VanderWalde; Ramzi G Salloum; Tsai-Ling Liu; Mark C Hornbrook; Maureen C O'Keeffe Rosetti; Debra P Ritzwoller; Paul A Fishman; Jennifer Elston Lafata; Amir H Khandani; Bhishamjit S Chera
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-07       Impact factor: 6.223

Review 10.  Role of (18)F-FDG PET/CT in pre and post treatment evaluation in head and neck carcinoma.

Authors:  Bundhit Tantiwongkosi; Fang Yu; Anand Kanard; Frank R Miller
Journal:  World J Radiol       Date:  2014-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.